56.2
Klaus Boeker
Medizinische Hochschule Hannover
Klaus Boeker's research has significantly advanced our understanding of chronic hepatitis C, a major global health concern. Through the German Hepatitis C Registry, Boeker and colleagues have established prognostic markers for steatosis in HCV infection, highlighting its impact on clinical outcomes. Elevated liver enzymes also predict increased morbidity and mortality even after successful antiviral treatment. Furthermore, their work has shed light on weight gain following interferon-free treatment and the role of baseline risk factors in determining biochemical response to direct-acting antivirals. Boeker's research also explores the significance of detectable HCV RNA at treatment completion and the potential of circulating biomarkers for liver fibrosis diagnosis.